RSS
Rosenblum Silverman Sutton’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
34,392
-240
| -0.7% | -$78.3K | 2.72% | 11 |
|
|
2025
Q1 | $9.35M | Sell |
34,632
-143
| -0.4% | -$38.6K | 2.58% | 13 |
|
|
2024
Q4 | $8.18M | Sell |
34,775
-380
| -1% | -$89.4K | 2.06% | 16 |
|
|
2024
Q3 | $9.67M | Sell |
35,155
-45
| -0.1% | -$12.4K | 2.47% | 15 |
|
|
2024
Q2 | $8.55M | Sell |
35,200
-270
| -0.8% | -$65.6K | 2.29% | 15 |
|
|
2024
Q1 | $5.3M | Sell |
35,470
-467
| -1% | -$69.8K | 1.5% | 23 |
|
|
2023
Q4 | $6.88M | Sell |
35,937
-1,116
| -3% | -$214K | 2.19% | 16 |
|
|
2023
Q3 | $6.56M | Sell |
37,053
-100
| -0.3% | -$17.7K | 2.23% | 15 |
|
|
2023
Q2 | $7.06M | Sell |
37,153
-390
| -1% | -$74.1K | 2.33% | 15 |
|
|
2023
Q1 | $7.52M | Sell |
37,543
-2,340
| -6% | -$469K | 2.74% | 13 |
|
|
2022
Q4 | $9.48M | Sell |
39,883
-246
| -0.6% | -$58.5K | 3.45% | 10 |
|
|
2022
Q3 | $8.03M | Sell |
40,129
-2,477
| -6% | -$496K | 2.9% | 10 |
|
|
2022
Q2 | $6.21M | Buy |
42,606
+845
| +2% | +$123K | 2.02% | 17 |
|
|
2022
Q1 | $6.82M | Sell |
41,761
-598
| -1% | -$97.6K | 1.75% | 22 |
|
|
2021
Q4 | $7.18M | Sell |
42,359
-665
| -2% | -$113K | 1.62% | 25 |
|
|
2021
Q3 | $8.12M | Sell |
43,024
-417
| -1% | -$78.7K | 1.86% | 21 |
|
|
2021
Q2 | $7.36M | Buy |
43,441
+546
| +1% | +$92.6K | 1.66% | 22 |
|
|
2021
Q1 | $6.06M | Buy |
42,895
+805
| +2% | +$114K | 1.55% | 26 |
|
|
2020
Q4 | $5.47M | Buy |
42,090
+235
| +0.6% | +$30.5K | 1.43% | 27 |
|
|
2020
Q3 | $6.09M | Buy |
41,855
+2,860
| +7% | +$416K | 1.71% | 23 |
|
|
2020
Q2 | $5.78M | Buy |
38,995
+1,325
| +4% | +$196K | 1.85% | 23 |
|
|
2020
Q1 | $4.1M | Buy |
+37,670
| New | +$4.1M | 1.64% | 23 |
|